The University of Chicago Header Logo

Connection

Ann Marie Mauer to Prodrugs

Back to Details
This is a "connection" page, showing publications Ann Marie Mauer has written about Prodrugs.
Ann Marie Mauer
Connection Strength
0.060
Prodrugs
  1. Phase I clinical trial of CEP-2563 dihydrochloride, a receptor tyrosine kinase inhibitor, in patients with refractory solid tumors. Invest New Drugs. 2004 Nov; 22(4):449-58.
    View in: PubMed
    Score: 0.060
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.